No turning back
McKnight’s Senior Living
Few industries are more a reflection of the constituents it serves than senior living. And keeping pace with its evolution is a head-spinning exercise…Read More.
Senior Care Pharmacy Coalition Response to the Healthcare Transparency Initiative
The Senior Care Pharmacy Coalition (SCPC) applauds your leadership and efforts to seek common sense approaches and bring greater transparency to the nation’s health care system. …Read More
Many overpay for prescriptions when co-pays are higher than drug prices: Study
People are often overpaying for prescription drugs when they are charged the insurance copay at the pharmacy, according to a new study from the University of Southern California…Read More.
We Must Hold Big Pharma Accountable For Predatory Pricing
It’s hard to remember now, but there once was a time when pharmaceutical companies were considered heroes, not villains…Read More.
The first target on drug prices: pharmacy benefit managers
After months of circular finger-pointing over high drug prices, lawmakers, administration officials and parts of the health care industry seem to have settled on an initial target: pharmacy benefit managers, the middlemen that health insurers and employers hire to negotiate with drug companies…Read More.
A costly PBM trick: set lower copays for expensive brand-name drugs than for generics
When the patent on a brand-name drug expires, and one or more generic versions enter the market, you’d expect consumers to pay less for the generic. That isn’t necessarily the case, thanks to the middlemen known as pharmacy benefit managers…Read More.
National LTC Pharmacy Advocacy Group: Cigna/Express Scripts Deal Heightens Salience of Gottlieb Comments Regarding PBMs and “Rigged Payment Schemes”
“Rapidly accelerating vertical and horizontal integration and growing secrecy threaten nation’s commitment to free and fair markets” – DoJ Should Reject Cigna/Express Scripts and Aetna/CVS Health…Read More.
SCPC Applauds FDA Commissioner Gottlieb’s Comments Saying PBMs Complicit in “Kabuki Drug-Pricing Constructs” and “Rigged Payment Scheme”
The Senior Care Pharmacy Coalition (SCPC) today praised Federal Drug Administration (FDA) Commissioner Scott Gottlieb’s pointed comments at an annual conference of health insurers in which he charged that pharmacy benefit manager (PBM) middlemen are complicit in “Kabuki drug pricing constructs” that expose consumers to high costs and discourage needed competition…Read More.
Comment Letter to CMS on the Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Draft Call Letter
The Senior Care Pharmacy Coalition appreciates the opportunity to comment on the Part D provisions of the Draft Call Letter titled, “Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Draft Call Letter.” The Draft Call Letter includes several proposals affecting beneficiary access to medications under the program and the ability of long-term care (LTC) pharmacies to dispense those medications and provide related consultative services…Read More